Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimer’s Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine

By  

Dementia and Geriatric Cognitive Disorders, Vol. 33, Iss. 2-3, 2012-05 ,pp. : 164-173

Karger

Access to resources Recommend Favorite

The Use of Biologics for Psoriasis in Asia-Pacific Region

By  

Current Rheumatology Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 149-152

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 3, 2009-09 ,pp. : 244-251

Karger

Access to resources Recommend Favorite

Donepezil for the Treatment of Mild to Moderate Alzheimer’s Disease in France: The Economic Implications

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 1-2, 2003-12 ,pp. : 5-13

Karger

Access to resources Recommend Favorite

Comprehensive, Individualized, Person-Centered Management of Community-Residing Persons with Moderate-to-Severe Alzheimer Disease: A Randomized Controlled Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 43, Iss. 1-2, 2017-01 ,pp. : 100-117

Karger

Access to resources Recommend Favorite